Clinical Trials Browser

Withdrawn × Lymphoma, T-Cell, Peripheral × romidepsin × Clear all

NCT03355768 2018-12-19

Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL

Phase 3 Withdrawn

Lymphoma, T-Cell, Peripheral